Hospitals profit from the 340B program but fail to improve care for vulnerable patients, research indicates
The 340B Drug Discount Program has made it possible for participating hospitals to reap financial benefits, but the hospitals do not appear to be using the additional revenue as the program intended, according to study results published online Jan. 24 by The New England Journal of Medicine.
